Contact Us
February 26–27, 2026

Psychedelics Therapeutics & Drug Development Conference 2026

New Orleans, LA
UBC is excited to join innovators and thought leaders at the Psychedelics Therapeutics & Drug Development Conference, an event dedicated to advancing research and clinical development in the emerging psychedelics space. This conference explores regulatory pathways, evidence generation, and patient safety considerations critical to bringing novel therapies to market.

As a trusted partner in clinical development and post-market programs, UBC provides integrated solutions that support evidence generation and ensure patient safety. Our expertise in real-world data collection, risk management, and regulatory compliance helps sponsors navigate the complexities of developing psychedelic therapies responsibly and effectively.

  • Evidence Development Solutions: Registries, observational studies, and real-world data strategies.
  • Safety & Risk Management Expertise: Pharmacovigilance, REMS programs, and global compliance.
  • Regulatory Guidance: Advanced analytics and technology to enhance trial efficiency.
  • Global Expertise: Proven strategies for emerging therapeutic categories.
  • Patient-Centric Approach: Ensuring safety and transparency throughout the product lifecycle.

Connect with UBC at the Psychedelics Therapeutics & Drug Development Conference to learn how we can support your evidence development and safety needs.
UBC Pinwheel logo

Schedule a Meeting

Learn More About UBC

We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.

Get in Touch

Other Events

View more
Boston skyline at dusk with reflections in the water, featuring historic ships and modern buildings under a colorful sky.
Trade show
October 15, 2026RSVP

World Patient Safety Congress Americas 2026

Meet UBC at the World Patient (Drug) Safety Congress Americas in Boston to explore pharmacovigilance and safety risk management solutions that protect patients and ensure specialty therapy programs remain compliant, scalable, and inspection ready.
Amsterdam city image showing canal
Trade show
September 24, 2026RSVP

World Patient Safety Congress Europe 2026

Meet UBC at the World Patient (Drug) Safety Congress Europe in Amsterdam to explore pharmacovigilance and safety risk management solutions that protect patients and keep specialty therapy programs compliant and inspection ready.
San Diego skyline illuminated by a vibrant sunset.
Trade show
September 16, 2026RSVP

14th Annual Outsourcing in Clinical Trials Southern California 2026

Meet UBC at OCT SoCal 2026 in San Diego to discuss evidence development solutions that generate meaningful real-world insights for clinical and post-market programs.

Schedule a Meeting
UBC logo white

Thank You for Connecting with UBC

.

 

What You Can Expect Next

.

  • Leverage automation to move fast
  • Always give customers a human to chat to
  • Automate customer support and close leads faster
Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Get Ready to Change Your Business

.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.